Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322360/
https://www.ncbi.nlm.nih.gov/pubmed/37416219
http://dx.doi.org/10.1155/2023/9823491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322360/
https://www.ncbi.nlm.nih.gov/pubmed/37416219
http://dx.doi.org/10.1155/2023/9823491

Ejemplares similares